Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FEZHL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,352
Award facts
- Contract value 100% obligated
- $53,352.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $53,352.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. Dupixent is a prescription biologic medication commonly used to treat atopic dermatitis, asthma, and other allergic conditions, supporting the military healthcare supply chain's need for specialized pharmaceutical products.
This delivery order reflects AmerisourceBergen's established role as a critical vendor within the DLA's medical supply procurement operations. The company's comprehensive pharmaceutical portfolio and proven ability to fulfill federal medical requirements through open competition have positioned it as a prime vendor capable of supplying a wide range of medications and medical supplies to Defense Health Agency beneficiaries, the U.S. Coast Guard, and other government healthcare systems. The rapid fulfillment timeline—with award and completion dates occurring on consecutive days—indicates this as a routine replenishment order within an active supply relationship supporting military personnel and veterans' healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FEZHL?
SPE2DB25FEZHL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FEZHL worth?
The government has obligated $53,352 on SPE2DB25FEZHL.
Is contract SPE2DB25FEZHL an order under another contract?
Yes. SPE2DB25FEZHL is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FEZHL competed?
The extent of competition for SPE2DB25FEZHL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award